Alexander Prezioso
Lake Hopatcong, NJNPI 1982852034
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$17,453,640in research payments, 2019–2025
Across 311 payments — averaging $56,121 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$8.3M
- Sanofi US Services Inc.$2.7M
- Organon$2.1M
- AbbVie$1.5M
- Sumitomo Pharma America, Inc.$534K
- Amgen$419K
- plus $1.9M from 8 others
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.